Management of Renal Disease

  • Author: Mohamed G. Atta, MD, MPH (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 3/14/17 (What's New)

Summary

  • Kidney function and damage should be evaluated in all patients with HIV when ART is initiated or changed as well as 2 times yearly (with the same methods to assess for trends) according to guidelines from the HIV Medicine Association of the IDSA (Management Guidelines)[Lucas 2014]
    • Patients with risk factors for kidney disease may be monitored more frequently
  • Kidney function should be evaluated by creatinine-based estimated GFR[Lucas 2014]
    • Serum Creatinine
      Normalizing Serum Creatinine
      Cystatin C
        Urine Biomarkers

        Action required

        Keywords: Renal Complications

        ©2018 Clinical Care Options, LLC. All Rights Reserved.

        The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.